Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...
Most Read
Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
Novel Biomarkers for Thrombosis Risk Prediction in Non–Small-Cell Lung Cancer: Insights from Recent Evidence
Venous thromboembolism (VTE) represents a significant cause of morbidity and mortality in patients with cancer,...
Disseminated Intravascular coagulation in solid and hematological cancers
Introduction There is a clear relationship between malignancy and deranged coagulation. Patients with cancer are at...
Coagulopathy and thrombosis in COVID-19 patients: parameters to be checked to assess disease severity
As the clinical evidence keeps on accumulating, we can clearly state that coronavirus disease 2019 (COVID-19) very...
Update on Oncology & Thrombosis to include COVID‐19. Your questions answered by our speakers
During our webinar “Update on Oncology & Thrombosis to include COVID‐19”, the interest from the audience was...
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
Cancer is a well-known risk factor for the occurrence of venous thromboembolism. In contrast, little research has been...
Prophylaxis for venous thromboembolism in COVID-19 Patients
The development of venous thromboembolism (VTE) is one of the major consequences observed in patients with Coronavirus...
Platelet-educated cancer cells and tumor-educated platelets: an egg-and-chicken debate
Platelets are versatile cells with known functions in hemostasis, thrombosis, inflammation, and several pathological...
Tools to raise thrombosis awareness in patients with cancer: a lesson from the EMPOWER study
Cancer-associated thrombosis (CAT) is the most frequent cause of death in patients with cancer after cancer itself . In...